In-depth blood immune profiling of Good syndrome patients

Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2023-11, Vol.14, p.1285088-1285088
Hauptverfasser: Torres-Valle, Alba, Aragon, Larraitz, Silva, Susana L, Serrano, Cristina, Marcos, Miguel, Melero, Josefa, Bonroy, Carolien, Arenas-Caro, Pedro Pablo, Casado, David Monzon, Olaizola, Pedro Mikel Requejo, Neirinck, Jana, Hofmans, Mattias, de Arriba, Sonia, Jara, María, Prieto, Carlos, Sousa, Ana E, Prada, Álvaro, van Dongen, Jacques J M, Pérez-Andrés, Martín, Orfao, Alberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered by the lack of data about the underlying immune alterations, a controversy existing on whether it is a unique diagnostic entity . a subtype of Common Variable Immune Deficiency (CVID). Here, we used high-sensitive flow cytometry to investigate the distribution of up to 70 different immune cell populations in blood of GS patients (n=9) compared to age-matched CVID patients (n=55) and healthy donors (n=61). All 9 GS patients displayed reduced B-cell counts -down to undetectable levels (
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1285088